The Continuous Infusion of Recombinant Activated Factor VIIa (rFVIIa) in Patients with Factor VIII Inhibitors Activates the Coagulation and Fibrinolytic Systems without Clinical Complications

Author: Baudo F.   Redaelli R.   Caimi T.M.   Mostarda G.   Somaini G.   de Cataldo F.  

Publisher: Elsevier

ISSN: 0049-3848

Source: Thrombosis Research, Vol.99, Iss.1, 2000-07, pp. : 21-24

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content